The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a https://cyrusgdrc371584.nytechwiki.com/11029030/retatrutide_vs_tirzepatide_a_comparative_analysis